Carcinoid Intestine Tumor clinical trials at UCLA

1 in progress, 0 open to eligible people

PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the safety, pharmacokinetics (PK), and exploratory dose response of paltusotine treatment in subjects with carcinoid syndrome. This study consists of a Randomized Treatment Phase followed by an Open-Label Extension (OLE) Phase.
Los Angeles, California and other locations

Last updated: January 31, 2024